491 related articles for article (PubMed ID: 18799315)
1. Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B.
Pretorius A; Ogunrombi MO; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2008 Oct; 16(19):8813-7. PubMed ID: 18799315
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP
Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878
[TBL] [Abstract][Full Text] [Related]
3. Interactions of 1-methyl-3-phenylpyrrolidine and 3-methyl-1-phenyl-3-azabicyclo[3.1.0]hexane with monoamine oxidase B.
Pretorius A; Ogunrombi MO; Fourie H; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2010 Jun; 18(11):4111-8. PubMed ID: 20451395
[TBL] [Abstract][Full Text] [Related]
4. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
[TBL] [Abstract][Full Text] [Related]
5. Assessment of structural requirements for the monoamine oxidase-B-catalyzed oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridine derivatives related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Mabic S; Castagnoli N
J Med Chem; 1996 Sep; 39(19):3694-700. PubMed ID: 8809158
[TBL] [Abstract][Full Text] [Related]
6. The tert-butoxyl radical mediated hydrogen atom transfer reactions of the Parkinsonian proneurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and selected tertiary amines.
Suleman NK; Flores J; Tanko JM; Isin EM; Castagnoli N
Bioorg Med Chem; 2008 Sep; 16(18):8557-62. PubMed ID: 18713667
[TBL] [Abstract][Full Text] [Related]
7. Deuterium isotope effect studies on the MAO-B catalyzed oxidation of 4-benzyl-1-cyclopropyl-1,2,3,6-tetrahydropyridine.
Anderson AH; Kuttab S; Castagnoli N
Biochemistry; 1996 Mar; 35(10):3335-40. PubMed ID: 8605171
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships in the inhibition of monoamine oxidase B by 1-methyl-3-phenylpyrroles.
Ogunrombi MO; Malan SF; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2008 Mar; 16(5):2463-72. PubMed ID: 18065227
[TBL] [Abstract][Full Text] [Related]
9. Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B.
Ottoboni S; Caldera P; Trevor A; Castagnoli N
J Biol Chem; 1989 Aug; 264(23):13684-8. PubMed ID: 2788162
[TBL] [Abstract][Full Text] [Related]
10. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
Herraiz T; Arán VJ; Guillén H
Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997
[TBL] [Abstract][Full Text] [Related]
11. Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.
Herraiz T; Guillén H; Arán VJ; Idle JR; Gonzalez FJ
Toxicol Appl Pharmacol; 2006 Nov; 216(3):387-98. PubMed ID: 16870220
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs.
Youngster SK; Sonsalla PK; Sieber BA; Heikkila RE
J Pharmacol Exp Ther; 1989 Jun; 249(3):820-8. PubMed ID: 2786564
[TBL] [Abstract][Full Text] [Related]
13. Studies on the monoamine oxidase-B-catalyzed biotransformation of 4-azaaryl-1-methyl-1,2,3,6-tetrahydropyridine derivatives.
Nimkar SK; Mabic S; Anderson AH; Palmer SL; Graham TH; de Jonge M; Hazelwood L; Hislop SJ; Castagnoli N
J Med Chem; 1999 May; 42(10):1828-35. PubMed ID: 10346935
[TBL] [Abstract][Full Text] [Related]
14. The behaviour of aryl pyrrolines with monoamine oxidase.
Williams CH; Lawson J
Neurobiology (Bp); 1999; 7(2):225-33. PubMed ID: 10591055
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and monoamine oxidase B catalyzed oxidation of C-4 heteroaromatic substituted 1,2,3,6-tetrahydropyridine derivatives.
Nimkar SK; Anderson AH; Rimoldi JM; Stanton M; Castagnoli KP; Mabic S; Wang YX; Castagnoli N
Chem Res Toxicol; 1996 Sep; 9(6):1013-22. PubMed ID: 8870990
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanism of MPTP oxidation by human liver monoamine oxidase B.
Gessner W; Brossi A; Bembenek ME; Fritz RR; Abell CW
FEBS Lett; 1986 Apr; 199(1):100-2. PubMed ID: 3485542
[TBL] [Abstract][Full Text] [Related]
17. Depletion of heart norepinephrine in mice by some analogs of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine).
Fuller RW; Hemrick-Luecke SK
Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):147-56. PubMed ID: 3496637
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors.
Herraiz T; Guillén H
Food Chem Toxicol; 2011 Aug; 49(8):1773-81. PubMed ID: 21554916
[TBL] [Abstract][Full Text] [Related]
19. [Catalytic biotransformation of physiologically active 1-methyl-4- aryl-1,2,3,6-tetrahydropyridines under the action of monoaminooxidase].
Bachurin SO; Sablin SO; Grishina GV; Gaĭdarova EL; Dubova DG
Bioorg Khim; 1989 May; 15(5):620-6. PubMed ID: 2788421
[TBL] [Abstract][Full Text] [Related]
20. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.
Harik SI; Riachi NJ; Hritz MA; Berridge MS; Sayre LM
J Pharmacol Exp Ther; 1993 Aug; 266(2):790-5. PubMed ID: 8355208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
